GLP-1 drugs: what Minnesota Medical Assistance paid

Q: Does a paid prescription mean Medical Assistance covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Medical Assistance shows a published payment figure for 8 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Medical Assistance's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Medical Assistance’s payment record shows

In 2026Q1, the product Medical Assistance paid for most often was Wegovy®, at 19,166 prescriptions¹³ of the 49,052 to 49,205^{1,7,13,19,25,31,37,43} across all 8 products, or 39 percent of the published count.

Medical Assistance itself reimbursed at least $54,586,853 for these products in the quarter, about $1,113 per prescription. Pharmacies were paid $54,717,720 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,295.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Medical Assistance finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Medical Assistance. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Medical Assistance paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Medical Assistance paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both6,331 managed care, 712 direct	7,043¹	14%	$7,325,762	$7,345,034	$1,040
tirzepatideMounjaro®	Both4,306 managed care, 491 direct	at least 4,797⁷	10%	$5,013,311	$5,044,645	$1,045
semaglutideWegovy®	Both16,825 managed care, 2,341 direct	at least 19,166¹³	39%	$24,818,337	$24,879,745	$1,295
semaglutideOzempic®	Both14,336 managed care, 2,106 direct	at least 16,442¹⁹	34%	$16,268,326	$16,285,962	$989
semaglutideRybelsus®	Both196 managed care, 17 direct	at least 213²⁵	<1%	$211,719	$212,935	$994
liraglutideSaxenda®	Both242 managed care, 26 direct	268³¹	<1%	$299,796	$299,796	$1,119
liraglutideVictoza®	Both292 managed care, 83 direct	375³⁷	<1%	$242,755	$242,755	$647
liraglutideliraglutide (generic)	Both	at least 731⁴³	1%	$406,846	$406,846	$557

Medical Assistance publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 375 against 6,578. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 42.8 to 42.9 prescriptions per thousand people enrolled in Medical Assistance, on an average of 1,146,749 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 4 of the 168 product-quarters it holds a row for here, which is 2 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Medical Assistance pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Medical Assistance paid for each product, quarter by quarter

Prescriptions Medical Assistance paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 116 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$117,950 paid	at least 1,901 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$1,933,890 paid	at least 3,499 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$3,594,422 paid	at least 5,918 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$6,048,053 paid	at least 7,370 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$7,535,408 paid	at least 7,512 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$7,766,158 paid	at least 7,647 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$7,944,369 paid	at least 7,938 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$8,243,650 paid	at least 8,327 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$8,688,500 paid	7,043 paid prescriptions in the quarter (2026Q1)¹Count$7,325,762 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 81 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$76,661 paid	at least 267 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$248,955 paid	at least 623 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$600,788 paid	at least 920 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$892,908 paid	at least 1,210 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,128,822 paid	at least 1,605 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,508,143 paid	at least 1,632 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$1,602,164 paid	at least 1,564 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$1,594,299 paid	at least 2,147 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$2,238,571 paid	at least 2,242 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$2,545,767 paid	at least 3,053 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$3,248,299 paid	at least 4,703 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$4,894,491 paid	at least 4,706 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$4,784,704 paid	at least 5,365 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$5,467,924 paid	at least 4,797 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$5,013,311 paid
semaglutideWegovy®range 6,642 to 24,610	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	at least 101 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld¹⁸At least$133,713 paid	at least 435 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$565,697 paid	at least 485 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$644,151 paid	at least 370 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$486,336 paid	at least 453 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$593,381 paid	at least 2,974 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$3,827,621 paid	6,642 paid prescriptions in the quarter (2023Q2)¹⁶Count$8,476,158 paid	7,244 paid prescriptions in the quarter (2023Q3)¹⁶Count$9,247,367 paid	7,404 paid prescriptions in the quarter (2023Q4)¹⁶Count$9,525,981 paid	8,836 paid prescriptions in the quarter (2024Q1)¹⁵Count$11,349,972 paid	13,398 paid prescriptions in the quarter (2024Q2)¹⁵Count$17,467,008 paid	17,341 paid prescriptions in the quarter (2024Q3)¹⁵Count$22,473,361 paid	16,898 paid prescriptions in the quarter (2024Q4)¹⁵Count$22,029,203 paid	19,622 paid prescriptions in the quarter (2025Q1)¹⁴Count$25,485,634 paid	22,379 paid prescriptions in the quarter (2025Q2)¹⁴Count$29,139,919 paid	24,377 paid prescriptions in the quarter (2025Q3)¹⁴Count$31,830,594 paid	24,610 paid prescriptions in the quarter (2025Q4)¹⁴Count$32,238,078 paid	at least 19,166 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$24,818,337 paid
semaglutideOzempic®range 801 to 4,977	801 paid prescriptions in the quarter (2021Q1)²⁴Count$713,520 paid	at least 955 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$870,992 paid	at least 1,063 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$971,772 paid	at least 1,146 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,066,692 paid	at least 1,465 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,190,020 paid	at least 1,796 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,460,107 paid	at least 2,074 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,690,388 paid	2,308 paid prescriptions in the quarter (2022Q4)²³Count$1,922,368 paid	at least 2,995 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$2,542,781 paid	3,839 paid prescriptions in the quarter (2023Q2)²²Count$3,252,502 paid	at least 4,193 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$3,591,200 paid	at least 4,130 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$3,569,868 paid	4,977 paid prescriptions in the quarter (2024Q1)²¹Count$4,479,805 paid	at least 8,894 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$8,409,960 paid	at least 13,271 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$12,588,860 paid	at least 13,365 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$13,017,638 paid	at least 15,796 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$15,611,791 paid	at least 19,288 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$18,862,976 paid	at least 19,131 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$18,443,159 paid	at least 19,213 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$18,537,621 paid	at least 16,442 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$16,268,326 paid
semaglutideRybelsus®	at least 122 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$119,732 paid	at least 154 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$138,288 paid	at least 171 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$170,198 paid	at least 160 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$167,320 paid	at least 228 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$198,725 paid	at least 274 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$236,111 paid	at least 295 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$269,126 paid	at least 310 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$281,577 paid	at least 387 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$396,403 paid	at least 428 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$440,915 paid	at least 486 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$490,732 paid	at least 511 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$510,131 paid	at least 524 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$491,762 paid	at least 400 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$411,015 paid	at least 420 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$423,286 paid	at least 411 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$474,530 paid	at least 357 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$467,386 paid	at least 486 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$527,119 paid	at least 336 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$321,787 paid	at least 301 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$287,522 paid	at least 213 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$211,719 paid
liraglutideSaxenda®range 70 to 1,687, down 156 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld2 of 2 product codes withheld	70 paid prescriptions in the quarter (2021Q4)³⁶Count$72,884 paid	209 paid prescriptions in the quarter (2022Q1)³⁵Count$226,899 paid	494 paid prescriptions in the quarter (2022Q2)³⁵Count$571,025 paid	808 paid prescriptions in the quarter (2022Q3)³⁵Count$958,437 paid	1,149 paid prescriptions in the quarter (2022Q4)³⁵Count$1,384,429 paid	1,300 paid prescriptions in the quarter (2023Q1)³⁴Count$1,575,045 paid	1,616 paid prescriptions in the quarter (2023Q2)³⁴Count$1,902,751 paid	1,687 paid prescriptions in the quarter (2023Q3)³⁴Count$1,968,339 paid	857 paid prescriptions in the quarter (2023Q4)³⁴Count$1,037,125 paid	362 paid prescriptions in the quarter (2024Q1)³³Count$421,411 paid	460 paid prescriptions in the quarter (2024Q2)³³Count$557,272 paid	508 paid prescriptions in the quarter (2024Q3)³³Count$610,346 paid	421 paid prescriptions in the quarter (2024Q4)³³Count$518,753 paid	440 paid prescriptions in the quarter (2025Q1)³²Count$525,184 paid	582 paid prescriptions in the quarter (2025Q2)³²Count$660,982 paid	645 paid prescriptions in the quarter (2025Q3)³²Count$753,193 paid	424 paid prescriptions in the quarter (2025Q4)³²Count$490,969 paid	268 paid prescriptions in the quarter (2026Q1)³¹Count$299,796 paid
liraglutideVictoza®range 375 to 10,717, down 87 on the quarter before	6,578 paid prescriptions in the quarter (2021Q1)⁴²Count$6,520,103 paid	7,869 paid prescriptions in the quarter (2021Q2)⁴²Count$7,853,062 paid	8,261 paid prescriptions in the quarter (2021Q3)⁴²Count$8,276,313 paid	8,030 paid prescriptions in the quarter (2021Q4)⁴²Count$8,174,090 paid	8,930 paid prescriptions in the quarter (2022Q1)⁴¹Count$7,970,936 paid	9,732 paid prescriptions in the quarter (2022Q2)⁴¹Count$8,701,883 paid	10,195 paid prescriptions in the quarter (2022Q3)⁴¹Count$9,120,528 paid	10,225 paid prescriptions in the quarter (2022Q4)⁴¹Count$9,191,206 paid	10,717 paid prescriptions in the quarter (2023Q1)⁴⁰Count$9,998,884 paid	10,435 paid prescriptions in the quarter (2023Q2)⁴⁰Count$9,691,695 paid	9,886 paid prescriptions in the quarter (2023Q3)⁴⁰Count$9,081,399 paid	9,671 paid prescriptions in the quarter (2023Q4)⁴⁰Count$8,772,742 paid	8,184 paid prescriptions in the quarter (2024Q1)³⁹Count$5,582,675 paid	5,687 paid prescriptions in the quarter (2024Q2)³⁹Count$3,855,098 paid	3,296 paid prescriptions in the quarter (2024Q3)³⁹Count$2,177,908 paid	1,800 paid prescriptions in the quarter (2024Q4)³⁹Count$1,274,630 paid	1,354 paid prescriptions in the quarter (2025Q1)³⁸Count$847,830 paid	395 paid prescriptions in the quarter (2025Q2)³⁸Count$251,854 paid	401 paid prescriptions in the quarter (2025Q3)³⁸Count$260,237 paid	462 paid prescriptions in the quarter (2025Q4)³⁸Count$302,772 paid	375 paid prescriptions in the quarter (2026Q1)³⁷Count$242,755 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 1,179 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$769,188 paid	at least 1,150 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$750,868 paid	at least 1,006 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$521,142 paid	at least 1,285 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$625,080 paid	at least 1,071 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$510,263 paid	at least 1,052 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$520,919 paid	at least 731 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$406,846 paid

What this page cannot tell you

Whether Medical Assistance covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Minnesota in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MN
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1564"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MN
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1947"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MN
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "2047"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MN
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "101"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MN
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like ZEPBOUND%, state MN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MN
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like ZEPBOUND%, state MN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MN
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1186"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MN
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1348"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MN
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "456"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MN
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "333"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MN
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "104"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MN
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like MOUNJARO%, state MN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MN
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "6755"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MN
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "8862"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MN
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "6554"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MN
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "3983"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MN
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "310"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MN
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "59"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MN
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "6052"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MN
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "6994"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MN
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "5349"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MN
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1618"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MN
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1074"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MN
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "614"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MN
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "119"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MN
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "249"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MN
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "240"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MN
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "205"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MN
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "127"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MN
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "78"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MN
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "242"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MN
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "597"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MN
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "486"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MN
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1600"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MN
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1128"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MN
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "58"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MN
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "171"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MN
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "760"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MN
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "4593"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MN
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "5834"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MN
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "5657"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MN
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "4587"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MN
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MN", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "288"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MN
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "493"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MN
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "888"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MN
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like LIRAGLUTID%, state MN, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MN
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like LIRAGLUTID%, state MN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MN
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MN", "product_name": "product_name like LIRAGLUTID%, state MN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Medical Assistance covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.